Eskitis Institute, Griffith University, Brisbane, QLD 4111, Australia.
J Nat Prod. 2010 May 28;73(5):985-7. doi: 10.1021/np900834g.
A drug discovery program aimed at identifying new antimalarial leads from a prefractionated natural product library has resulted in the identification of a new bromotyrosine alkaloid, psammaplysin G (1), along with the previously isolated compound, psammaplysin F (2). When tested against two different strains of the parasite Plasmodium falciparum (Dd2 and 3D7), 2 displayed IC(50) values of 1.4 and 0.87 microM, respectively, while 1 showed 98% inhibition at 40 microM against the chloroquine-resistant (Dd2) strain of P. falciparum.
一个旨在从预分馏天然产物库中鉴定新抗疟先导化合物的药物发现计划,已经鉴定出一种新的溴代酪氨酸生物碱,即 psammaplysin G(1),以及以前分离得到的化合物 psammaplysin F(2)。当对两种不同的疟原虫寄生虫(Dd2 和 3D7)进行测试时,化合物 2 对 Dd2 株和 3D7 株的 IC50 值分别为 1.4 和 0.87 μM,而化合物 1 对氯喹耐药(Dd2)株的抑制率为 98%,其浓度为 40 μM。